KeithDAaronsonMD
Cardiology • Ann Arbor, MIHeart Failure & Transplantation
Professor, Internal Medicine, University of Michigan
Are you Dr. Aaronson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 112 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
# Level
Ann Arbor, MI 48109Phone+1 888-287-1082
Summary
- Dr. Keith Aaronson, MD is a cardiologist in Ann Arbor, Michigan. He is currently licensed to practice medicine in Michigan, New York, and Pennsylvania. He is affiliated with University of Michigan Medical Center and Corewell Health Dearborn Hospital.
Education & Training
University of Pennsylvania Health SystemFellowship, Cardiovascular Disease, 1990 - 1993
University of MichiganInternship, Internal Medicine, 1984 - 1985
Baylor College of MedicineClass of 1984
Certifications & Licensure
MI State Medical License 1986 - 2027
NY State Medical License 1993 - 1996
PA State Medical License 1990 - 1994- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Hawthorn Extract Randomized Blinded Chronic Heart Failure (HERB CHF) Trial Start of enrollment: 2000 Jan 01
- Harefield Recovery Protocol Study for Patients With Refractory Chronic Heart Failure Start of enrollment: 2007 Jul 01
- Identifying and Facilitating Ventricular Recovery on Mechanical Support Start of enrollment: 2008 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 17 citationsA challenge to equity in transplantation: Increased center-level variation in short-term mechanical circulatory support use in the context of the updated U.S. heart tr...Thomas Cascino, Josef Stehlik, Wida S. Cherikh, Yulin Cheng, Tessa M.F. Watt
The Journal of Heart and Lung Transplantation. 2021-09-16 - 40 citationsChanges in the United States Adult Heart Allocation Policy: Challenges and Opportunities.Supriya Shore, Jessica R. Golbus, Keith D. Aaronson, Brahmajee K. Nallamothu
Circulation. Cardiovascular Quality and Outcomes. 2020-09-29 - 505 citationsA Fully Magnetically Levitated Circulatory Pump for Advanced Heart FailureMandeep R. Mehra, Yoshifumi Naka, Nir Uriel, Daniel J. Goldstein, Joseph C. Cleveland
The New England Journal of Medicine. 2017-02-02
Authored Content
- Adverse Effects of Delayed Transplant Listing Among Patients with Implantable Left Ventricular Assist DevicesFebruary 2018
- Adverse Effects of Delayed Transplant Listing Among Patients with Implantable Left Ventricular Assist DevicesFebruary 2018
Press Mentions
Less Than 10% of Adults with Heart Failure Get Cardiac Rehab Despite Medicare ExpansionNovember 8th, 2021- At Just 35, Woman Suffers 2 Heart Attacks in 3 Days Due to Rare ConditionJuly 10th, 2020
- Who's to Blame? These Three Scientists Are at the Heart of the Surgisphere COVID-19 ScandalJune 8th, 2020
- Join now to see all
Grant Support
- Clinical Trial Of Crataegus Oxycantha Extract In Chronic Heart FailureNational Center For Research Resources2004–2005
- Efficacy &Safety Of SDZ RAD Immunosuppressive Therapy In Heart TransplantsNational Center For Research Resources2000–2002
- Hawthorn For Congestive Heart FailureNational Heart, Lung, And Blood Institute1998
- Clinical Index To Predict Survival In Heart FailureNational Heart, Lung, And Blood Institute1995–1996
- Clinical Index To Predict Survival In Heart FailureNational Heart, Lung, And Blood Institute1993–1994
- Clinical Index To Predict Survival In Heart FailureNational Heart, Lung, And Blood Institute1992
